SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes.
Diabetol Metab Syndr
; 15(1): 25, 2023 Feb 19.
Article
in En
| MEDLINE
| ID: mdl-36804863
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Observational_studies
Language:
En
Journal:
Diabetol Metab Syndr
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: